NCT00613769View on ClinicalTrials.gov

Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

1,073

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2012

Conditions
Infection Prophylaxis in Colo Rectal Surgery
Interventions
DRUG

trimethoprim-sulfamethoxazole + metronidazole

trimethoprim-sulfamethoxazole (160mg/800mg)p.o.+ metronidazole (1200mg)p.o.

DRUG

cefuroxime and metronidazole

cefuromime 1500mg i.v. + metronidazole 1500mg i.v.

Trial Locations (6)

416 85

Department of Surgery, University hospital Sahlgrenska/Östra, Gothenburg

301 85

Department of Surgery and oncology, Halland Hospital in Halmstad, Halmstad

371 85

Department of surgery, Community Hospital i Karlskrona, Karlskrona

601 82

Vrinnevi hospital, Norrköping

541 85

Department of surgery, Skövde

451 80

Department of Surgery, NU-hospitals, Uddevalla

All Listed Sponsors
lead

Halmstad County Hospital

OTHER

NCT00613769 - Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery | Biotech Hunter | Biotech Hunter